Joseph K. Belanoff, Chief Executive Officer at CORCEPT THERAPEUTICS INC (CORT), sold 434,230 shares at $19.01 ($8.3M) on 2018-12-12, disclosed to the SEC on 2018-12-14.
Open-market sale of $8.3M CORT by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.01 | 217,115 | $4.1M | 50.0% |
| 2 | $19.01 | 217,115 | $4.1M | 50.0% |
| Total | $19.01 avg | 434,230 | $8.3M | 100% |
| Filing → |
| CORT | SELL | 2026-03-27 | $2.6M | — | Filing → |
| CORT | SELL | 2025-12-03 | $3.2M | — | Filing → |
| CORT | SELL | 2025-11-05 | $4.9M | — | Filing → |